9:00 am Check-In & Light Breakfast
Workshop A
9:30 am Collaborating on Industry-Uniting Strategies to Support Bioactive Ingredient Innovation
Synopsis
This is your premier opportunity to unite with R&D and regulatory teams from other infant formula manufacturers and ingredient developers in an interactive and discussion-based session to:
- Identify consistent and consolidated regulatory strategies for bioactive ingredients and discuss the regulatory requirements of bringing new infant formulas to market
- Leverage lessons learned from successful and failed conversations to inform future approaches
- Enhance synergy between regulatory and R&D teams to ensure efficient feedback loops and decision-making
- Reflecting on historical perspectives surrounding infant formula development
12:30 pm Networking Lunch
Workshop B
1:30 pm Optimizing Clinical Trial Design & Efficiency Through Suitable Endpoint Identification
Synopsis
Uncertainty remains around how components of human breast milk can inform the development of infant formula, particularly when incorporating novel ingredients. Strategic endpoint selection is essential to ensure clinical trials generate meaningful and reliable data to support regulatory goals. This workshop is your opportunity to deep dive into:
- Selecting relevant clinical endpoints that measure growth and tolerance, cognitive, immunological function and microbiome impact based on the application of the formula
- Examine how these endpoints would be classified in a study (primary, secondary, exploratory, etc.)
- Determine the best collection methodology to get a product to market